Vasomune Therapeutics, Inc. ("Vasomune"), a clinical-stage biopharmaceutical company developing therapies that target vascular leak, today announced that Dr. Harold Kim, Chief Scientific Officer, will ...
Janae Pettit told Newsweek: "I feel pretty certain it would have turned into something much worse." ...
YOU ARE HERE: Home > Guidelines and Clinical Policy > 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock ...
aDivision of Chronic Disease Research Across the Lifecourse (CoRAL), Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, Boston, MA, USA ...
ePain Research Institute, Institute of Life Course and Medical Sciences, University of Liverpool, Walton Centre NHS Foundation Trust, Liverpool, UK fCentre for Pain Research, Department of Psychology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results